Becton, Dickinson to pay $175M to settle claims over misleading …

The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued …

$175
OFF

Becton, Dickinson To Pay $175M To Settle Claims Over Misleading …

3 weeks from now

The SEC on Monday said that Becton, Dickinson (NYSE:BDX) agreed to pay a $175M civil penalty to settle charges that it misled investors regarding the risks associated with continued …

msn.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer …

sec.gov

$175
OFF

BD To Pay $175M To Settle Charges Of Misleading Investors On …

3 weeks from now

Dec 17, 2024 · Dive Brief: BD will pay a $175 million civil penalty to settle charges from the Securities and Exchange Commission that the company misled investors about problems with …

medtechdive.com

$175
OFF

BD Agrees To Pay $175 Mln To Settle With SEC Over Alaris System ...

3 weeks from now

Dec 17, 2024 · (RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and …

businessinsider.com

$175
OFF

Becton Dickinson Settles Charges Over Infusion Pump Risks, SEC Says

3 weeks from now

Dec 16, 2024 · The SEC said Becton Dickinson agreed to pay a $175 million civil penalty to settle the charges, which also allege that the company overstated its income by failing to disclose …

yahoo.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors

3 weeks from now

Dec 16, 2024 · The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey- based medical device manufacturer …

nasdaq.com

$175
OFF

BD Pays $175M To Settle SEC Claims It Failed To Report Infusion …

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission (SEC) today announced settled charges against Becton, Dickinson and Company (BD), a New Jersey-based medical device …

medicaldesigndevelopment.com

$175
OFF

Financial Crime Weekly: Becton, Dickinson And Co. Pays $175

3 weeks from now

Dec 21, 2024 · The Securities and Exchange Commission on Monday announced it had settled charges against Becton, Dickinson and Company BDX, known as BD, for repeatedly …

benzinga.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors On …

3 weeks from now

Dec 20, 2024 - Compliance & Ethics - Becton, Dickinson and Company (BD), a New Jersey-based medical device manufacturer, has agreed to pay a $175 million civil penalty to the …

grcreport.com

$175
OFF

Becton Dickinson To Pay SEC $175M Over Pump Claims

3 weeks from now

Law360 (December 16, 2024, 7:47 PM EST) -- Becton Dickinson & Co. has agreed to pay $175 million to settle the U.S. Securities and Exchange Commission's allegations that the medical …

law360.com

$175
OFF

BD Resolves Previously Disclosed SEC Investigation - Yahoo Finance

3 weeks from now

As part of the settlement, BD has agreed to pay $175 million to the SEC, an amount that was reserved and disclosed in the company's fiscal year 2024 Form 10-K and was contemplated in …

yahoo.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Probe

3 weeks from now

Dec 17, 2024 · Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most important …

claimsjournal.com

$175
OFF

Becton Dickinson To Pay $175 Million Fine Related To SEC …

3 weeks from now

Dec 16, 2024 · Becton Dickinson has agreed to pay a $175 million fine to settle an investigation by the U.S. Securities and Exchange Commission. The previously disclosed investigation was …

morningstar.com

$175
OFF

Becton Dickinson To Pay $175 Million For Misleading Investors …

3 weeks from now

Dec 17, 2024 · * New Jersey-based company will also retain independent compliance consultant. Washington D.C. - The Securities and Exchange Commission today announced settled …

marketscreener.com

$175
OFF

Becton Dickinson To Pay $175 Million To Settle SEC Investigation …

3 weeks from now

Dec 17, 2024 · The Securities and Exchange Commission announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as …

jeffnewmanlaw.com

$175
OFF

Becton Dickinson Pays $175M For Misleading Investors About …

3 weeks from now

Dec 18, 2024 · Becton Dickinson medical device company will pay $175 million for "repeatedly" misleading investors about its Alaris infusion pump, a product the company knew was flawed …

complianceweek.com

$175
OFF

Becton Dickinson To Pay $175 Million Fine Related To SEC …

3 weeks from now

Dec 16, 2024 · Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by …

marketscreener.com

$175
OFF

Becton Dickinson Settles SEC Investigation With $175 Million Payout

3 weeks from now

Becton Dickinson and Company, a prominent medical technology firm, has agreed to settle a significant investigation by the U.S. Securities and Exchange Commission (SEC) by paying …

finsworld.com

FAQs about Becton, Dickinson to pay $175M to settle claims over misleading … Coupon?

Why did the SEC settle charges against BD?

The Securities and Exchange Commission announced settled charges against BD for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. ...

Did Becton Dickinson mislead investors about Alaris?

WASHINGTON (Reuters) - The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD) over allegations it misled investors about risks associated with its Alaris infusion pump. ...

Why did BD pay $175 million to the SEC?

(RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange Commission to resolve an investigation concerning past public disclosures and SEC reporting related to the BD Alaris System. ...

Did BD pay a $175 million civil penalty?

BD agreed to pay a $175 million civil penalty. According to the SEC’s order, BD determined in 2016 that software changes made to the Alaris pump required regulatory clearance from the Food and Drug Administration (FDA). ...

Why did BD discontinue a pump without a clearance?

However, BD did not have the data required for clearance, and generating the data would delay the release of new features, so BD continued selling the pump without clearance. By January 2019, BD identified more than 25 flaws in the pump’s software that its experts categorized as presenting risks of the greatest potential harm to patients. ...

Why did BD make misleading statements about regulatory risks?

Rather than inform investors that these issues heightened the risk that the FDA would limit BD's ability to continue selling Alaris—a product whose sales contributed about 10 percent of BD's profits—BD made misleading statements in its periodic reports about its regulatory risks. ...